Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$161.01 - $317.85 $632,769 - $1.25 Million
-3,930 Reduced 15.29%
21,776 $6.89 Million
Q3 2023

Nov 14, 2023

SELL
$164.66 - $218.08 $987 - $1,308
-6 Reduced 0.02%
25,706 $4.35 Million
Q2 2023

Aug 14, 2023

SELL
$176.32 - $240.22 $115,665 - $157,584
-656 Reduced 2.49%
25,712 $5.58 Million
Q1 2023

May 15, 2023

BUY
$161.33 - $204.36 $645 - $817
4 Added 0.02%
26,368 $4.79 Million
Q4 2022

Feb 14, 2023

BUY
$191.53 - $236.82 $1,532 - $1,894
8 Added 0.03%
26,364 $5.18 Million
Q3 2022

Nov 14, 2022

SELL
$123.79 - $277.42 $163,155 - $365,639
-1,318 Reduced 4.76%
26,356 $5.93 Million
Q2 2022

Aug 15, 2022

BUY
$93.97 - $143.33 $74,330 - $113,374
791 Added 2.94%
27,674 $3.5 Million
Q1 2022

May 16, 2022

SELL
$98.9 - $132.37 $15,824 - $21,179
-160 Reduced 0.59%
26,883 $3.41 Million
Q4 2021

Feb 14, 2022

SELL
$110.64 - $159.4 $108,648 - $156,530
-982 Reduced 3.5%
27,043 $3.54 Million
Q3 2021

Nov 15, 2021

BUY
$101.2 - $125.87 $41,390 - $51,480
409 Added 1.48%
28,025 $3.43 Million
Q2 2021

Aug 16, 2021

SELL
$107.45 - $135.95 $1.57 Million - $1.99 Million
-14,623 Reduced 34.62%
27,616 $3.15 Million
Q1 2021

May 17, 2021

BUY
$95.46 - $133.08 $4.03 Million - $5.62 Million
42,239 New
42,239 $5.08 Million
Q3 2020

Nov 13, 2020

SELL
$71.31 - $109.74 $570,480 - $877,920
-8,000 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$62.14 - $117.21 $497,120 - $937,680
8,000 New
8,000 $892,000

Others Institutions Holding KRTX

About Karuna Therapeutics, Inc.


  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track Fred Alger Management, LLC Portfolio

Follow Fred Alger Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.